[1]邓兵,刘萍.直接经皮冠状动脉介入治疗急性心肌梗死的研究进展[J].西部中医药,2020,33(02):137-140.[doi:10.12174/j.issn.1004-6852.2020.02.39]
　DENG Bing,LIU Ping.Research Progress of Direct PCI in the Treatment of AMI[J].Western Journal of Traditional Chinese Medicine,2020,33(02):137-140.[doi:10.12174/j.issn.1004-6852.2020.02.39]
点击复制

直接经皮冠状动脉介入治疗急性心肌梗死的研究进展
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年02期
页码:
137-140
栏目:
出版日期:
2020-02-15

文章信息/Info

Title:
Research Progress of Direct PCI in the Treatment of AMI
文章编号:
1004-6852(2020)02-0137-04
作者:
邓兵，刘萍
上海中医药大学附属龙华医院，上海 200032
Author(s):
DENG Bing, LIU Ping△
Longhua Hospital Shanghai University of TCM, Shanghai 200032, China
关键词:
直接PCI; 冠脉微循环障碍; 研究进展
Keywords:
direct PCI;  coronary microvascular dysfunction;  research progress
分类号:
R825.4
DOI:
10.12174/j.issn.1004-6852.2020.02.39
文献标志码:
A
摘要:
查阅国内、外相关文献，发现西医治疗急性心肌梗死(acute myocardial infarction，AMI)分别从抑制血小板聚集、扩张血管和其他非药物治疗手段等方面入手，在此基础上从口服制剂和注射制剂的角度对中西医结合干预AMI直接经皮冠状动脉介入(percutaneouscoronary intervention,PCI)治疗冠脉微循环障碍的研究现状进行总结、归纳。
Abstract:
Through consulting the related papers at home and abroad, Western medicine in the treatment of AMI were summarized from inhibiting platelet aggregation, dilating blood vessels and other non-drug therapy, to summarize research status of integrative medicine in the intervention for AMI and direct PCI in the treatment forcoronary microvascular dysfunction from the angles of oral formulation and injection.

相似文献/References:

[1]李艺,张艳,孙晓宁.基于“气血理论”探讨冠脉微循环障碍病机及治法[J].西部中医药,2023,36(11):120.[doi:10.12174/j.issn.2096-9600.2023.11.27]
　LI Yi,ZHANG Yan,SUN Xiaoning.Exploration into the Pathogenesis and Therapeutic Methods of Coronary Microvascular Disease Based on "Qi and Blood Theory"[J].Western Journal of Traditional Chinese Medicine,2023,36(02):120.[doi:10.12174/j.issn.2096-9600.2023.11.27]

备注/Memo

备注/Memo:
收稿日期：2019-03-31*基金项目：上海市科学技术委员会科研计划项目课题(16401971900)。作者简介：邓兵(1967—)，男，硕士学位，主任医师。研究方向：心血管疾病的临床诊治。通讯作者：刘萍(1966—)，女，主任医师，教授，博士研究生导师。研究方向：心血管疾病的临床诊治。
更新日期/Last Update: 2020-02-15